LV-MAX™ Lentiviral Packaging Mix is an optimized single formulation containing a defined mixture of three packaging plasmids: pLP1, pLP2, and
XP0006A
CTS™ LV-MAX™ Production Medium
Vector Copy Distribution at a Single-Cell Level Enhances
Bladder Cancer‐Derived Small Extracellular Vesicles Promote Tumor
Integrative functional genomics decodes herpes simplex virus 1
SARS-CoV-2 S-D614G S-Protein Mutant Pseudotyped Lentiviral
Metformin Targets Mitochondrial Electron Transport to Reduce Air
Frontiers NOTCH1-mutated chronic lymphocytic leukemia displays
Spatial multi-omic map of human myocardial infarction
Lipid bodies containing oxidatively truncated lipids block antigen
High-titer, one-step lentivirus packaging systems
The phenotypic landscape of essential human genes - ScienceDirect
Decoding myofibroblast origins in human kidney fibrosis
pPACK-ID Integrase-defective Lentiviral Packaging Mix